Oct. 23 Financial Quick Takes: Alexion buyback; plus RAPT, NeuroRX and Oyster Point

Billion-dollar buyback for Alexion
The board of Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) has approved a $1 billion share repurchase authorization, with no expiration

Read the full 216 word article

How to gain access

Continue reading with a
two-week free trial.